Investor Hub

Novavax, Inc. is a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases.

Latest investor presentation
Latest clinical presentation
Latest quarterly earnings
Annual report
Latest publications, posters & presentations
Global ticker
NASDAQNVAX

SEC

Access filings by selecting the date range and type using the drop-down menus.

NASDAQNVAX
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesMay 15, 2018Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
8-KReport of unscheduled material events or corporate eventMay 10, 2018Open Report of unscheduled material events or corporate event in HTML.Open Report of unscheduled material events or corporate event in DOC file.Open Report of unscheduled material events or corporate event in PDF file.Open Report of unscheduled material events or corporate event in XLS file.
10-QQuarterly report which provides a continuing view of a company's financial positionMay 9, 2018Open Quarterly report which provides a continuing view of a company's financial position in HTML.Open Quarterly report which provides a continuing view of a company's financial position in DOC file.Open Quarterly report which provides a continuing view of a company's financial position in PDF file.Open Quarterly report which provides a continuing view of a company's financial position in XLS file.Open Quarterly report which provides a continuing view of a company's financial position in XBLR Viewer.Open Quarterly report which provides a continuing view of a company's financial position in XBLR file.
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Apr 30, 2018Open Official notification to shareholders of matters to be brought to a vote ("Proxy") in HTML.Open Official notification to shareholders of matters to be brought to a vote ("Proxy") in DOC file.Open Official notification to shareholders of matters to be brought to a vote ("Proxy") in PDF file.Open Official notification to shareholders of matters to be brought to a vote ("Proxy") in XLS file.
DEFA14AAdditional proxy soliciting materials - definitiveApr 30, 2018Open Additional proxy soliciting materials - definitive in HTML.Open Additional proxy soliciting materials - definitive in DOC file.Open Additional proxy soliciting materials - definitive in PDF file.Open Additional proxy soliciting materials - definitive in XLS file.
8-KReport of unscheduled material events or corporate eventApr 13, 2018Open Report of unscheduled material events or corporate event in HTML.Open Report of unscheduled material events or corporate event in DOC file.Open Report of unscheduled material events or corporate event in PDF file.Open Report of unscheduled material events or corporate event in XLS file.
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Apr 13, 2018Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in HTML.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in DOC file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in PDF file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in XLS file.
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Apr 11, 2018Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in HTML.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in DOC file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in PDF file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in XLS file.
8-KReport of unscheduled material events or corporate eventMar 15, 2018Open Report of unscheduled material events or corporate event in HTML.Open Report of unscheduled material events or corporate event in DOC file.Open Report of unscheduled material events or corporate event in PDF file.Open Report of unscheduled material events or corporate event in XLS file.
10-KAnnual report which provides a comprehensive overview of the company for the past yearMar 14, 2018Open Annual report which provides a comprehensive overview of the company for the past year in HTML.Open Annual report which provides a comprehensive overview of the company for the past year in DOC file.Open Annual report which provides a comprehensive overview of the company for the past year in PDF file.Open Annual report which provides a comprehensive overview of the company for the past year in XLS file.Open Annual report which provides a comprehensive overview of the company for the past year in XBLR Viewer.Open Annual report which provides a comprehensive overview of the company for the past year in XBLR file.
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2018Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.
SC 13G/AAmendment to a previously filed SC 13GFeb 9, 2018Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.
SC 13G/AAmendment to a previously filed SC 13GFeb 8, 2018Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.
4Statement of changes in beneficial ownership of securitiesFeb 1, 2018Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
EFFECTNotice from the SEC of registration effectivenessJan 16, 2018Open Notice from the SEC of registration effectiveness in HTML.Open Notice from the SEC of registration effectiveness in DOC file.Open Notice from the SEC of registration effectiveness in PDF file.Open Notice from the SEC of registration effectiveness in XLS file.
CORRESPCorrespondence from the Filer to the SECJan 10, 2018Open Correspondence from the Filer to the SEC in HTML.Open Correspondence from the Filer to the SEC in DOC file.Open Correspondence from the Filer to the SEC in PDF file.Open Correspondence from the Filer to the SEC in XLS file.
8-KReport of unscheduled material events or corporate eventJan 9, 2018Open Report of unscheduled material events or corporate event in HTML.Open Report of unscheduled material events or corporate event in DOC file.Open Report of unscheduled material events or corporate event in PDF file.Open Report of unscheduled material events or corporate event in XLS file.
UPLOADCorrespondence from the SEC to the FilerJan 9, 2018Open Correspondence from the SEC to the Filer in HTML.Open Correspondence from the SEC to the Filer in DOC file.Open Correspondence from the SEC to the Filer in PDF file.Open Correspondence from the SEC to the Filer in XLS file.
1-25      26-43
Why invest with us

We are a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases.

For much of my four-decade career, I’ve worked with biotech companies trying to solve significant health challenges, including HIV. Novavax is uniquely positioned to help end this pandemic with our protein-based vaccine. I believe in NVX-CoV2373 so much.

I came out of retirement to join the fight.

Lisa Dunkle
Vice President, Global Medical Lead for Coronavirus Vaccine

Get notifications for investor updates

Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings, and more.

Go to email subscription 

Investor inquiries

Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at ir@novavax.com

Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.